Top compounds associated with response to GMFG


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.28 2e-08
mRNA linifanib CTRPv2 pan-cancer AAC 0.28 3e-08
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 3e-08
mRNA quizartinib CTRPv2 pan-cancer AAC 0.29 3e-08
mRNA AZD7762 CTRPv2 pan-cancer AAC 0.25 4e-08
mRNA alisertib CTRPv2 pan-cancer AAC 0.24 5e-08
mRNA TG-101348 GDSC1000 pan-cancer AAC 0.28 6e-08
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-07
mRNA tivozanib CTRPv2 pan-cancer AAC 0.27 1e-07
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.32 1e-07
Download CSV